Trial of BMS-986012 in Combination With Platinum and Etoposide
Status:
Active, not recruiting
Trial end date:
2021-07-26
Target enrollment:
Participant gender:
Summary
The purpose of this this study is to administer BMS-986012 in Combination with Platinum and
Etoposide as First-line Therapy in Extensive Small Cell Lung Cancer.